Dentatorubropallidoluysian atrophy (DRPLA)
Definition:
References:
-
[1]. C A Ross, et al. Polyglutamine pathogenesis. Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1005-11. [Content Brief]
[2]. Dobrila D Rudnicki, et al. Repeat expansion and autosomal dominant neurodegenerative disorders: consensus and controversy. Expert Rev Mol Med. 2003 Aug 22;5(21):1-24. [Content Brief]
[3]. Frederick C Nucifora Jr, et al. Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity. J Biol Chem. 2003 Apr 11;278(15):13047-55. [Content Brief]
[4]. G Schilling, et al. Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA. Neuron. 1999 Sep;24(1):275-86. [Content Brief]
[5]. I Kanazawa, et al. Dentatorubral-pallidoluysian atrophy or Naito-Oyanagi disease. Neurogenetics. 1998 Dec;2(1):1-17. [Content Brief]
[6]. I Kanazawa, et al. Molecular pathology of dentatorubral-pallidoluysian atrophy. Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1069-74. [Content Brief]
[7]. Masahisa Katsuno, et al. Molecular genetics and biomarkers of polyglutamine diseases. Curr Mol Med. 2008 May;8(3):221-34. [Content Brief]
Molarity Calculator
Dilution Calculator
